These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9402370)

  • 1. Effect of treatment with zidovudine on subsequent incidence of Kaposi's sarcoma.
    Joffe MM; Hoover DR; Jacobson LP; Kingsley L; Chmiel JS; Visscher BR
    Clin Infect Dis; 1997 Nov; 25(5):1125-33. PubMed ID: 9402370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.
    Hermans P; Lundgren J; Sommereijns B; Pedersen C; Vella S; Katlama C; Lüthy R; Pinching AJ; Gerstoft J; Pehrson P; Clumeck N
    AIDS; 1996 Jul; 10(8):911-7. PubMed ID: 8828749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the effect of zidovudine on Kaposi's sarcoma from observational data using a rank preserving structural failure-time model.
    Joffe MM; Hoover DR; Jacobson LP; Kingsley L; Chmiel JS; Visscher BR; Robins JM
    Stat Med; 1998 May; 17(10):1073-102. PubMed ID: 9618771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
    Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
    Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
    Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
    J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.
    Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A
    J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort Study.
    Opravil M; Hirschel B; Bucher HC; Lüthy R
    Int J STD AIDS; 1999 Jun; 10(6):369-75. PubMed ID: 10414879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohort.
    Dore GJ; Li Y; Grulich AE; Hoy JF; Mallal SA; Mijch AM; French MA; Cooper DA; Kaldor JM
    AIDS; 1996 Oct; 10(12):1401-6. PubMed ID: 8902070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma: a reevaluation.
    Orfanos CE; Husak R; Wölfer U; Garbe C
    Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
    Jones JL; Hanson DL; Dworkin MS; Jaffe HW
    J Acquir Immune Defic Syndr; 2000 Jul; 24(3):270-4. PubMed ID: 10969352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
    Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS.
    Eberly LE; Ohman PA; Neaton JD; Price RW; Abrams DI
    AIDS; 2000 May; 14(8):995-1000. PubMed ID: 10853981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 and AIDS-associated Kaposi's sarcoma: a nested case control study within the Multicenter AIDS Cohort Study.
    Dourado I; Martínez-Maza O; Kishimoto T; Suzuki H; Detels R
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):781-8. PubMed ID: 9171222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.
    Erlandson KM; Gudza I; Fiorillo S; Ndemera B; Schooley RT; Gwanzura L; Borok M; Campbell TB
    Int J Infect Dis; 2014 Jul; 24():6-10. PubMed ID: 24769175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
    Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
    J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
    Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
    Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.
    Dore GJ; Hoy JF; Mallal SA; Li Y; Mijch AM; French MA; Cooper DA; Kaldor JM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):39-43. PubMed ID: 9377123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.
    Glesby MJ; Hoover DR; Weng S; Graham NM; Phair JP; Detels R; Ho M; Saah AJ
    J Infect Dis; 1996 Jun; 173(6):1477-80. PubMed ID: 8648224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS. AIDS in Europe Study Group.
    Hermans P; Lundgren J; Sommereijns B; Katlama C; Chiesi A; Goebel FD; Gonzales-Lahoz J; Proenza R; Barton SE; Pedersen C; Clumeck N
    AIDS; 1997 Mar; 11(4):525-31. PubMed ID: 9084801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.